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Abstract
Mice carrying loss-of-function mutations in certain Notch pathway genes display increased and accelerated pancreatic endocrine
development, leading to depletion of precursor cells followed by pancreatic hypoplasia. Here, we have investigated the effect of expressing
a constitutively active form of the Notch1 receptor (Notch1ICD) in the developing pancreas using the pdx1 promoter. At e10.5 to e12.5, we
observe a disorganized pancreatic epithelium with reduced numbers of endocrine cells, confirming a repressive activity of Notch1 upon the
early differentiation program. Subsequent branching morphogenesis is impaired and the pancreatic epithelium forms cyst-like structures
with ductal phenotype containing a few endocrine cells but completely devoid of acinar cells. The endocrine cells that do form show
abnormal expression of cell type-specific markers. Our observations show that sustained Notch1 signaling not only significantly represses
endocrine development, but also fully prevents pancreatic exocrine development, suggesting that a possible role of Notch1 is to maintain
the undifferentiated state of common pancreatic precursor cells.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Vertebrate pancreatic development is initiated when
endodermal cells posterior to the prospective stomach ini-
tiate budding dorsal to the prospective duodenum (Hebrok
et al., 1998, 2000; Kim et al., 1997; Wessells and Cohen,
1967). Slightly later, a ventral region opposite the dorsal
pancreatic anlage also initiates a pancreatic program, form-
ing the ventral pancreatic bud. Between e13 and e14 in the
mouse, a major wave of differentiation events, known as the
secondary transition (Pictet and Rutter, 1972; Pictet et al.,
1972) is initiated during which pancreatic exocrine cells and
mature insulin-producing -cells first appear (Herrera,
2000; Jensen et al., 2000a). Recent studies have pointed to
the importance of Notch-mediated control of pancreatic fate
determinations via control of neurogenin3 (Ngn3). All pan-
creatic endocrine cell differentiation is dependent on the
ngn3 gene, which is transiently expressed in endocrine
precursor cells during fetal development (Gradwohl et al.,
2000). Forced expression of ngn3 in all pancreatic precursor
cells converts these into endocrine cells, with a concomitant
loss of exocrine cell types (Apelqvist et al., 1999; Schwit-
zgebel et al., 2000). In addition to regulating neurogenesis
through a repressive effect on neurogenin activity (Artava-
nis-Tsakonas et al., 1999; Chitnis and Kintner, 1996; Kopan
and Turner, 1996), the Notch signaling pathway is involved
in the selection of endodermal endocrine cells. Inactivation
of Notch signaling components Dll1 and RBP-J led to
increased formation of endocrine cells in the pancreas
(Apelqvist et al., 1999). Also, mice lacking the Notch1
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effector gene Hes1, encoding a repressor of the hairy/en-
hancer-of-split bHLH type (Sasai et al., 1992), display a
similar conversion of pancreatic epithelial precursor cells
into endocrine cells (Jensen et al., 2000b). These data sug-
gest that Notch activity is required for proper expansion of
pancreatic precursor cells, but the severity of these mutants
does not allow investigation of how these genes function
later in pancreatic development. The expression of Notch
receptor genes in the pancreas suggests additional roles later
in pancreatic development. Notch1 is expressed together
with Hes1 within the pancreatic epithelium prior to the
secondary transition, after which it is expressed in the acinar
cells (Apelqvist et al., 1999; Jensen et al., 2000b; Lammert
et al., 2000). Expression of Notch3ICD, a repressor of
Notch1 in vitro, leads to deficiency in exocrine development
(Apelqvist et al., 1999). Notch3 is normally expressed in the
pancreatic mesenchyme (Jensen et al., 2000a; Lammert et
al., 2000). These observations led to the suggestion that
pancreatic exocrine specification is conferred by the instruc-
tive activity of Notch1 (Apelqvist et al., 1999). However,
exocrine development can occur in Hes1 mutant mice
(Jensen et al., 2000b), showing that putative Notch1 mod-
ulation of exocrine differentiation would be Hes1-indepen-
dent.
To further examine the role of Notch1 in pancreatic
development, we have generated mice expressing a consti-
tutively active form of Notch1 (Notch1ICD) under control of
pdx1 regulatory sequences which direct expression to pan-
creatic precursor cells and surrounding endodermal tissues,
such as posterior stomach and duodenum. We observe a
disorganized pancreatic epithelium with reduced numbers
of endocrine cells. Branching morphogenesis is abated, and
the pancreatic epithelium appears to form a cyst-like struc-
ture with ductal features that contains a few endocrine cells
but no acinar cells. The remaining pancreatic cells appear
arrested in a progenitor state. The few endocrine cells that
do form show abnormal expression of cell type-specific
markers. Together, these data show that attenuation of
Notch signaling is required for pancreatic morphogenesis as
well as differentiation of both pancreatic endocrine and
Fig. 1. Generation of truncated intracellular forms of Notch1, -2 and -3, their transactivating potential, and subcellular localization. (A) Graphic representation
of generated intracellular Notch-forms. (B) NIH-3T3 cells transiently transfected with the above forms as listed, and pGL2-pmHES1 (194 to 160) or
pGL2-pmHES1-c (60 to 160) reporter plasmids. pGL2-pmHES1-c (60 to 160) is a truncated control version of the mouse HES1 promoter without
Su(H)/CSL sites. The DNA-binding Notch cofactor Su(H)/CSL cannot bind to the HES1 promoter when the sites are deleted, thus serving as a control. (C)
Overexpression by transient transfection of NIH-3T3 fibroblasts followed by immunocytochemical staining for the Myc epitope shows that Notch1ICD display
a nuclear localization. All other NotchICD forms also localize to the nucleus (not shown). (D) Nuclear localization is also observed in mouse insulinoma cells,
HC9, immunoperoxidase staining shown. Scale bar is 5 m (C, D).
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exocrine cells. Our observations are consistent with the
notion that Notch1 signaling acts to maintain pancreatic
cells in a progenitor state.
Materials and methods
Constructs
Rat Notch-1, -2, and -3ICD were cloned by nested PCR
from e14.0 Wistar rat pancreas random primed cDNA.
Primers are available on request. Amino acid information is
given for initiation and end points. Codons for methionines
were incorporated as translational start codons. Notch1ICD:
(aa 1751) MRRQHG, (aa 2531) PEAFK; Notch2ICD: (aa
1703) MKRKHGF, (aa 2471) MQVYA; Notch3ICD: (aa
1670) MKREHST, (aa 2318) RQVMA. In the second PCR,
the coding sequence for the c-Myc tag EQKLISEEDLN was
added to the C-terminal end, and an EcoRI site was incor-
porated 5 and 3. The PCR products were digested with
EcoRI and ligated into pBKCMV (Stratagene). The start
codon of the alpha peptide used in blue/white selection was
removed by cutting with NheI and SpeI followed by religa-
tion. pmHES1 was cloned from genomic NOD mouse tail
DNA by PCR: 5 primer, 5-GGGGTACCCTCAGGC-
GCGCGCCATTGGCC-3; 3 primer, 5-GAAGATCTG-
CTTACGTCCTTTTACTTGAC-3. The reaction was cut
with BglII and KpnI, ligated with BglII and KpnI cut pGL2-
basic (Promega). To generate the control reporter pmHES1-C:
5 primer, 5-GGTACCACACGAGCCGTTCGCGTGCAG-
3; and 3 primer, 5-GAAGATCTGCTTACGTCCTTT-
TACTTGAG-3 were used. The generation of the pPDX1--
globin-Notch1ICD construct was performed as follows. pBKII
was cut with EcoRI and blunt-end ligated to remove the EcoRI
site. The 4.5-kb XbaI–SmaI PDX1 promoter fragment previ-
ously described (Wu et al., 1997) was inserted by cutting the
vector with XbaI and SmaI. The endogenous EcoRI site in the
PDX1 promoter was removed by cutting with EcoRI and blunt
end ligation, generating pBlueSKII–pPDX1. The -globin ex-
pression cassette was removed by cutting with BamHI (Sasaki
and Hogan, 1994), and ligated into pBluSKII, generating
pBluSKII-betaglobin. pBluSKII-betaglobin was cut with SpeI,
filled in using klenow, and subsequently digested with XbaI.
The EcoRI-modified PDX1 promoter was released from
pBlueSKII–pPDX1 by cutting with XbaI and SmaI, and
ligated into SpeI–XbaI opened pBluSKII-betaglobin gener-
ating pBluSKII–pPDX1–betaglobin. Notch1ICD was in-
serted by cutting pBluSKII–pPDX1–globin with EcoRI
Fig. 2. Notch1ICD is nuclear localized in e12.0 transgenic embryos. Wild
type embryos do not stain with the antibody against the Myc tag on
Notch1ICD (C). pPDX1-Notch1ICD transgenic embryos display a nuclear
staining (D) when stained against, clearly seen on the merged DNA stain
TO-PRO3 image (F). On adjacent sections, PDX1 (B) is detected in the
same area as Myc. There is, however, not complete overlap; this could be
due to mosaic or extinguished expression of the transgene. Scale bars are
15 m (A–D) or 5 m (E–F).
Fig. 3. Disruption of pancreatic budding and reduction of glucagon-ex-
pressing cells (e10.5). (A, C, E) Serial sections at the developing fore/
midgut boundary, stained for PDX1, glucagon, and Nkx6.1, respectively.
PDX1 is expressed in the pancreatic buds and lateral gut wall (A). Nkx6.1
is restricted to the definitive buds (arrowheads, E). Glucagon is expressed
in multiple cells already clustering in the dorsal bud, but the ventral bud is,
at this time point, only commencing endocrinogenesis (C). (B, D, F) Serial
sections of the fore/midgut region of a transgenic littermate. Bud morphol-
ogy is disrupted and a large region of the endoderm appears to bud from
multiple points (B). We cannot conclusively define proper dorsal and
ventral pancreas domains, hence dp and vp. Most cells have acquired a
pancreatic fate, as Nkx6.1 is expressed throughout the budding structure
(F) overlapping the PDX1 domain. Glucagon is also expressed in the
transgenic Nkx6.1 area that may correspond to the dorsal pancreas,
although in a reduced number of cells (D). st-m, stomach mesoderm; st-e,
stomach endoderm; arrowhead in (F), stomach epithelium. Scale bar is
50 m.
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and ligating in the EcoRI Notch1ICD fragment thus gener-
ating pBluSKII–pPDX1–globin–Notch1ICD.
Cell culture, transfection, and immunocytochemistry
NIH-3T3 and betaHC9 cells were grown in DMEM 1000
mg/l glucose supplied with 10% FBS. Transfections were
carried out O/N in 24-well plates (NUNC) with Lipo-
fectamine (Life Tech.) as described in the protocol of the
manufacturer using 50 ng of the NotchICD effector plasmids
and 150 ng of reporter plasmid. Cells were harvested 40–46
h posttransfection. Immunocytochemistry was performed as
described (Madsen et al., 1986). Rabbit -cMyc, A-14 (San-
ta Cruz Biotech) was used at: DIF 1:300/HRP-AEC 1:2000.
Generation and identification of transgenic embryos
Transgenic embryos were generated by pronuclear mi-
croinjection with the pPDX-1-globin-NotchICD 8.5 frag-
ment, purified from BssHII linearized pBluSKII-pPDX1-
globin-Notch1ICD, in fertilized eggs obtained from a cross
between F1(C57BL/6J  DBA/2J) mice, as described
(Hogan et al., 1994). Viable embryos were transferred to
pseudopregnant females for development until harvest time:
at e10.5, e12.0, e12.5, e14.5, and e18.5. Transgenic em-
bryos were identified by PCR: 5 primer, 5-CTCCAGGC-
CAATGATGGCTCCAGGG-3; 3 primer, 5-GAG-
GAGACAATGGTTGTCAACAGAGTA-3. A total of 18
transgenic embryos were identified: e10.5, n  4; e12.0, n
 4; e12.5, n  3; e14.5, n  2; e18.5, n  5.
Antisera and immunohistochemistry
Tissue isolation and immunohistochemistry were per-
formed as described (Jensen et al., 2000b). Images were
recorded by a Hamamatsu C5810 CCD cooled camera, and
further processed in Adobe Photoshop. Primary antibodies
were used as follows in immunohistochemistry: rabbit
-Myc (sc-789, Santa Cruz), TSA 1:800; rabbit Hm-253
-PDX1 (Stoffers et al., 1997), TSA 1:10000/AEC 1:5000;
rabbit -amylase (A8273, Sigma), TSA 1:10000; guinea pig
-insulin (GP31, Novo Nordisk A/S), DIF 1:500; mouse
-insulin (HUI 18, Novo Nordisk A/S), DIF 1:100; mouse
-glucagon (GLU-001, Novo Nordisk A/S), DIF 10 g/ml;
rabbit -glucagon (A565, Novo Nordisk A/S) DIF 1:100;
rabbit -somatostatin (SOM-018, Novo Nordisk A/S) DIF
10 g/ml; rabbit -HES1 (Ito et al., 2000) TSA 1:400;
rabbit -Nkx6.1, (174, own) TSA 1:3000; rabbit -GLUT2
(Thorens et al., 1992) TSA 1:1500; rabbit -GLUT2
(AB1342, Chemicon), TSA 1:3000; rabbit -CPA (1810-
006, Anawa) TSA 0.5 g/ml; rabbit -Mist1 (Pin et al.,
2000), TSA 1:1000; rabbit -Ngn3 (Schwitzgebel et al.,
2000), TSA, 1:3000, TSA 1:6000; sheep -CarA-II (PC076,
The binding site), TSA 30 g/ml; rabbit -IAPP (771,
own), TSA, 1:2000. In Fig. 5, DAPI was used at 0.1 g/ml
as a counterstain. In Fig. 2, TO-PRO-3 was used at 1:10000
as a counterstain.
Results
Constitutively active Notch forms accumulate in the
nucleus but differ in transactivation capacity
We generated constitutively active forms of rat Notch1,
Notch2, and Notch3 (Notch1ICD, -2ICD, and -3ICD) including
the PEST-domain known to target the proteins for degrada-
tion (Fig. 1A) (Fryer et al., 2002; Oberg et al., 2001; Qiu et
al., 2000; Santolini et al., 2000). A C-terminal Myc-tag was
included in all constructs allowing immunohistochemical
detection of the protein. To identify the most potent activa-
tor of Hes1 transcription, we transiently transfected NIH-
3T3 cells with the NotchICD forms together with a Notch1-
responsive Hes1 promoter-luciferase reporter (Fig. 1B). As
shown previously, Notch1ICD activates this promoter depen-
dent on the presence of the Su(h)/CSL binding site (Jarriault
et al., 1995), cell type, and promoter (Mizutani et al., 2001;
Shimizu et al., 2002). Similarly, Notch2ICD was found to
activate pHES1-luc, but only at 50% of the Notch1ICD
activity. Notch3ICD only weakly activates the Hes1 pro-
moter. These differences are not due to variations in protein
levels as Western blot showed comparable expression levels
for the different NotchICD (data not shown). As these dif-
ferences could be explained by a difference in nuclear
uptake within the NIH-3T3 cells, we performed immuno-
cytochemistry visualizing the protein with antisera against
the Myc-tag. In all cases, NotchICD forms were found to be
mainly nuclear localized (Fig. 1C, and data not shown). We
then generated a construct containing Notch1ICD, coding
sequences under control of 4.5 kb of the pancreatic-duode-
num-homeobox-1 (pdx1) gene promoter, hereafter called
pPDX1-Notch1ICD. pdx1 is normally transcribed at high
levels in pancreatic epithelium and at lower levels in caudal
stomach and duodenum (Offield et al., 1996). The construct
was active in the mouse insulinoma cell line HC9, which
expresses the endogenous pdx1 gene (Fig. 1D). As in NIH-
3T3 fibroblasts, we observed mainly a nuclear localization
of Notch1ICD.
Expression of Notch1ICD results in defective pancreatic
development
We performed pronuclear injections of eggs obtained
from C57BL/2J  DBA/2J F1 females with pPDX1-
Notch1ICD linearized DNA, and isolated embryos at various
time points prior to birth. No lines were established. All but
two of the identified carriers (5 time points, n  18) dis-
played a consistent endodermal phenotype of the distal
foregut. In pPDX1-Notch1ICD transgenic e12.0 embryos,
we detected nuclear Notch1ICD using the C-terminal Myc
tag (Fig. 2D) in most of the cells in the PDX1-positive area
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(Fig. 2B). Wild-type littermates were negative for the Myc
tag in the PDX1-positive pancreas area (Fig. 2A and C).
Nuclear localization of Notch1ICD is evident at higher mag-
nification (Fig. 2F).
We first investigated the expression of PDX1 and Nkx6.1
in e10.5 transgenic embryos. Sections through the fore/
midgut boundary (Fig. 3B, D, and F) did not reveal the
distinct dorsal and ventral pancreatic buds of the normal
embryos (Fig. 3A, C, and E). Instead, multiple epithelial
evaginations were found (Fig. 3B). The majority of the
epithelial cells in this area expressed Nkx6.1 (Fig 3F),
whereas in the wild type, Nkx6.1 is restricted to the dorsal
and ventral pancreatic buds (Fig. 3E). We next investigated
whether expression of Notch1ICD would affect early endo-
crine development. At e10.5, endocrine cells are normally
differentiating in both the dorsal and ventral pancreas (Ahl-
gren et al., 1996, 1997; Jensen et al., 2000b). We observed
a marked decrease in the number of glucagon endocrine
cells in transgenics compared with wild type (Fig. 3C
and D).
In e12.5 transgenic embryos, we observed a PDX1-pos-
itive stratified cuboidal epithelium (Fig. 4B), beginning at
the stomach and terminating posterior to the pancreatic
domain in the duodenum. Cells in this domain were iden-
tified as being pancreatic, as these expressed the pancreatic
marker Nkx6.1 (Fig. 4D). At e12.5, normal pancreatic de-
velopment occurs through extensive branching of pancreatic
epithelial cells, and endocrine cells are found primarily as
clusters of glucagon-positive cells embedded within the
epithelium (Fig. 4A, C, E, and G). In the transgenic epithe-
lium, no typical epithelial branching was observed and
glucagon cells were found as single cells and in reduced
numbers (Fig. 4B, D, F, and H) compared with wild-type
littermates (Fig. 4A, C, E, and G). In transgenic embryos,
normal stomach development was observed anterior to the
PDX1 expression domain, and posterior of the PDX1 do-
main, intestinal development seemed unaffected.
Reduction in the numbers of glucagon-producing cells
prompted us to analyze Ngn3 expression as Ngn3 is known
to induce differentiation of glucagon-producing cells in
chick and mouse (Grapin-Botton et al., 2001; Schwitzgebel
et al., 2000; Apelqvist et al., 1999). While Ngn3 immuno-
reactivity is readily detectable in normal pancreas (Fig. 4E),
we observed Ngn3 nuclei at a very low frequency in the
transgenic PDX1 epithelium (Fig. 4F). Inhibition of Ngn3
demonstrates the repressive function of Notch1ICD either
directly (Sriuranpong et al., 2002) or through Notch1ICD
target genes (Lee et al., 2001). As the Hes genes Hes1 and
Hes5 are direct targets of Notch1 (Jarriault et al., 1995,
1998; Ohtsuka et al., 1999), we examined whether Hes
genes were induced by expression of Notch1ICD. Expression
of Hes-1 in the transgenic endoderm is readily detectable in
large numbers of PDX1 cells but surprisingly not in all
cells (Fig. 4H), and comparable to the expression pattern
found in e12.5 wild type pancreas (Fig. 4G). This may
suggest the presence of other signals regulating Hes1, or
alternatively, an oscillatory expression of Hes1 as recently
reported (Hirata et al., 2002) where a resulting cyclic
change in protein concentrations of Hes1 might make it
impossible to detect uniform expression of this protein. It
should also be noted that Hes1 expression in wild-type
embryos is significant, suggesting that active Notch signal-
ing is ongoing in these cells during normal development.
However, in contrast to the case in the transgenic embryos,
Notch signaling can be terminated in wild-type embryos,
allowing normal differentiation to proceed. At e14.5, the
posterior stomach and the duodenum are positive for
PDX1 in wild-type embryos, while the pancreas ex-
presses both PDX1 and Nkx6.1. In the transgenic em-
bryos, a large PDX1/Nkx6.1, but hormone-negative
ventricular space has developed in the midgut region. Next
to this, a network of PDX1/Nkx6.1 single cell-layer
epithelia has formed, intermingled with glucagon-express-
ing cells (data not shown). Later, at e18.5, macroscopic
examination of transgenic midguts revealed an almost com-
plete absence of pancreatic development (n  5; Fig. 5B
and D) compared with wild type (Fig. 5A and C). Various
degrees of single cell-layer epithelial cystic development
were observed in the midgut region (Fig. 5F). Translucent
tissue in connection with the cyst was composed of mesen-
chyme containing scarce amounts of epithelium positive for
pancreatic markers (Fig. 5B and F, and see Figs. 6, 7, and
8): this epithelium will be referred to as “rudimentary pan-
creas” in the following. PDX1 is expressed in a scattered
pattern with varying strength (Fig. 5H), contrasting the
close to uniform expression observed at earlier stages.
Nkx6.1-positive cells are observed less frequently than the
PDX1-positive cells (see Fig. 7L, and data not shown). The
adjacent mesenchymal tissue of the transgenic embryos was
also thinned, to a thickness of a few cell layers. The PDX1-
negative, and Myc-negative anterior region of the stomach
was found to develop normally (not shown). Using the
incorporated Myc-tag to visualize transgene expression, we
found expression of Notch1ICD of the transgenic endoderm
(Fig. 5J), but not in wild type stomach (Fig. 5I) or pancreas
(data not shown). However, at this time point, Notch1ICD
can only be detected in the cytoplasm. A persistent problem
regarding the function of Notch is the difficulty of detecting
nuclear localization of activated Notch (Schroeter et al.,
1998). This can be explained by proteins that retain
Notch1ICD in the cytoplasm (Kopan, 1999; Shen et al.,
2002) or actively degrade the protein it the nucleus (Fryer et
al., 2002; Lamar et al., 2001; Oberg et al., 2001). The
cytoplasmic localization we detect seems to suggest that
Notch1ICD is not signaling at this time point and that the
observed phenotype at this time is due to perturbations of
cell fate decisions occurring earlier in development. How-
ever, we cannot rule out that signaling is ongoing since
Notch1ICD has been shown to act below the threshold of
detection (Schroeter et al., 1998).
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Impaired acinar pancreatic development of pPDX1-
Notch1ICD embryos
To further address the role of Notch signaling upon
pancreatic cell differentiation, we analyzed the histology of
the rudimentary pancreatic epithelium in transgenic em-
bryos for markers of differentiated acinar cells. As judged
from hematoxylin staining of pPDX1-Notch1ICD e18.5 em-
bryos, we could not observe the presence of acinar struc-
tures (Fig. 5F). In contrast, e18.5 wild-type pancreas con-
tains fully differentiated acinar cells (Fig. 5E) and central
islet aggregates. To verify that acinar differentiation was
impaired, we analyzed expression of three acinar cell-spe-
cific proteins: Mist1, amylase, and carboxypeptidase A
(CPA). Neither amylase nor CPA was detected in pPDX1-
Notch1ICD embryos (Fig. 6B and D), whereas expression
was high in wild-type littermates (Fig. 6A and C). Further-
more, absence of the acinar cell-specific bHLH transcription
factor Mist1 (Lemercier et al., 1997; Pin et al., 2000) con-
firmed that these cells had failed to develop (Fig. 6E and F).
Normally, acinar cells begin to differentiate e13.5, and we
decided to analyze transgenic embryos isolated closer to this
time point. We dissected midguts from e14.5 transgenic
embryos and performed an immunohistochemical analysis
of amylase expression. In wild type embryos, amylase ex-
pression was clearly visible in the forming acini (Fig. 6G),
but no amylase could be detected in transgenic embryos
(Fig. 6H). Apparently, acinar development is completely
blocked by expression of Notch1ICD.
Effects of Notch1ICD expression on pancreatic endocrine
development
Although a clear reduction in pancreatic endocrine cell
differentiation was seen in e10.5 and e12.5 transgenic em-
bryos, it was not completely blocked, and in fact, several
endocrine cells were observed later at e18.5. As PDX1
expression is maintained in the mature -cell, we sought to
clarify if forced expression of Notch1ICD would lead to
alterations in endocrine cell balance. Our initial analysis
showed that glucagon, insulin, and somatostatin-expressing
cells were present next to the reduced pancreatic-type epi-
thelium e18.5, prompting a more detailed phenotype anal-
ysis.
Glucagon-positive cells did not coexpress insulin, soma-
tostatin, or IAPP (Fig. 7A and B, and data not shown), nor
did they express Nkx6.1, or PDX1, but they did express
Pax6 and ISL1 (data not shown), and thus resemble normal
-cells. Normally, the population of - and -cells is bal-
anced in favor of the -cells at e18.5. Of the reduced
endocrine cell population, we here observe a strong bias
toward -cells, as extremely few insulin-positive cells were
found in transgenic pancreas (Fig. 7D and F). Similar to
normal -cells, these also expressed Pax6, ISL1 (data not
shown), Nkx6.1 (Fig. 7C and D), and PDX1 (Fig. 7E and F).
Additionally, we detected multiple Nkx6.1- and PDX1-
expressing cells that did not express insulin (Fig. 7C–F). To
evaluate if the insulin-expressing cells were of the mature
type, we analyzed for coexpression of GLUT2 and IAPP.
Unlike normal -cells, insulin-expressing cells in pPDX1-
Notch1ICD pancreas did not express GLUT2. (Fig. 7G and
H). We did observe insulin and IAPP coexpressing cells. All
insulin cells coexpressed IAPP; however, IAPP was also
detected in a proportion of cells that did not express insulin
(Fig. 7I and J).
The presence of Nkx6.1PDX1 and IAPP cells neg-
ative for insulin suggested the presence of immature -cells,
or alternatively, the presence of another cell type expressing
these markers. As -cells and somatostatin-producing
-cells are proposed to derive from the same lineage (Sosa-
Pineda et al., 1997), we investigated the properties of the
Fig. 4. Endocrine differentiation is delayed by downregulation of Ngn3 in
pPDX1-Notch1ICD embryos (e12.5). PDX1-negative glucagon cells have
delaminated from the uniform PDX1-positive protodifferentiated pancreas
endoderm (A). Most of the transgenic endoderm cells are positive for
PDX1; no delaminated glucagon cells are observed (B). Morphological the
transgenic endoderm resembles a nonbranched pancreatic epithelium. The
wild type pancreas (C) and transgenic (D) endoderm is positive for Nkx6.1.
Ngn3 is readily detected in wild type pancreas (E), but only a few weakly
expressing cells are observed in the transgenic endoderm (F). Hes1 is
expressed in the branching endoderm of the pancreas (G) and in the
transgenic endoderm in comparable pattern and intensity (H). Scale bar,
50 m.
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somatostatin-expressing cells. We find that somatostatin-
expressing cells were present in significant numbers, and as
in wild type embryos, we did not observe overlapping ex-
pression between IAPP and somatostatin (data not shown).
To evaluate the maturity of the somatostatin-expressing
cells we performed double stainings for somatostatin with
Nkx6.1 and PDX1. Normally, PDX1 is expressed in ap-
proximately 15% of the delta-cells in the mature islet, and
Nkx6.1 is expressed in approximately 10% of the early-
forming somatostatin cells (Oster et al., 1998), but never
expressed with somatostatin in the mature islet (Jensen et
al., 1996). In transgenic embryos, a few somatostatin-posi-
tive cells were found to express PDX1 but most did not
express PDX1, which is similar to wild-type (not shown).
However, when conducting somatostatin/Nkx6.1 double
staining, we surprisingly found that about 70% (114 cells
out of 162 cells) of the somatostatin-positive cells also
expressed Nkx6.1 (Fig. 7K and L). Staining with a mix of
insulin, somatostatin, and Nkx6.1, we find a large popula-
tion of Nkx6.1 cells that do not label with insulin or
somatostatin compared with wild type (data not shown),
suggesting that Notch1ICD-signaling impedes terminal en-
docrine differentiation.
Notch1ICD-signaling allows cells expressing duct markers
to form
The impaired differentiation of acinar cells and termi-
nally differentiated endocrine cells prompted us to investi-
gate the duct cell fate. Using a GLUT2 antibody, we found
that at e18.5 it stains pancreatic duct epithelium as well as
the membrane of -cells (Fig. 8A). In contrast to different
cytokeratin antibodies and the lectin Dolichos Biflorus Ag-
glutinin (DBA), the GLUT2 antibody is specific for pan-
creas as it does not stain in the duodenum (data not shown)
or the stomach (Fig. 8C), making it an optimal marker of
pancreatic cells at this stage. We find that the rudimentary
pancreas in the transgenic embryos stains strongly for
GLUT2 (Fig. 8B), DBA, and cytokeratin (data not shown)
and has duct-like morphology. The epithelia of the large
cystic structures were also positive for GLUT2 (Fig. 8D),
DBA, and cytokeratin (data not shown). The staining in the
cyst is weaker than in the rudimentary pancreas and patchy.
Staining wild type e18.5 tissue for carbonic anhydrase-II
(CA-II) gave a specific signal in the posterior stomach,
whereas the pancreas was unlabeled. Investigating the trans-
genic midgut with carbonic anhydrase-II and a duodenum-
specific marker, intestinal fatty acid binding protein (IFABP),
we observed that the cysts were negative for both (data not
shown). The presence of GLUT2 in the cyst epithelium and
DBA reactivity (data not shown) and absence of CA-II and
IFABP and the morphology suggest that the cyst is composed
mainly of undifferentiated pancreatic cells.
Staining for PDX1, Nkx6.1, and islet hormones, we find
all to be expressed in the cystic epithelia and rudimentary
pancreas to various degrees. PDX1-positive cells are fre-
Fig. 5. Altered morphology of the distal foregut of pPDX1-Notch1ICD
transgenic embryos (e18.5). (A, C) Dissected midgut of wild type
embryos showing a well-developed dorsal (A) and ventral (C) pan-
creas. (B, D) pPDX1-Notch1ICD transgenic midgut, showing lack of
pancreatic development; neither dorsal (B) nor ventral (D) pancreas is
present. The distal intestine displays no visual alteration. However, at
the fore–midgut junction, a strong endodermal phenotype is ob-
served, with a large cystic structure emanating where pancreas normally
is located. (E, F) Histological analysis of the fore/midgut region. Com-
pared with wild type (E), the posterior part of the stomach is converted
into a large thin-walled cyst (arrowheads), fused to the intestine.
The pyloric sphincter is absent. (H) PDX1 is expressed in the cyst
together with the transgene visualized by the Myc tag (J). Myc is not
detected in the PDX1 domain of normal stomach (G, I). dp, dorsal
pancreas; vp, ventral pancreas; st, stomach; sp, spleen; c, cyst; p,
pancreas; i, intestine; dp, rudimentary dorsal pancreas; vp, presumed
ventral pancreas; oe, oesophagus; ps, pyloric sphincter. Scale bar is
50 m.
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quent (Fig. 8F); Nkx6.1 and the hormones are found in a
more scattered expression pattern (Fig. 7L, and data not
shown). Cells that are strongly positive for PDX1 (Fig. 8F,
nonfilled arrows)—like in the rudimentary pancreas (Fig.
7F) and normal islets (Fig. 8E)—can be found to budding
off from the cyst. Weaker expressing PDX1-positive cells
are found in the cyst-proper (Fig. 8F), like in normal ducts
(Fig. 8E). This suggests that the cyst is pancreatic and to
some extent harbors undifferentiated pancreatic precursor
cells.
Discussion
Disturbed midgut development
This study demonstrates the importance of properly reg-
ulated Notch signaling during pancreatic development. The
abnormal morphogenesis and gene expression in the foregut
and midgut could be caused by several different mecha-
nisms. Expression of Notch1ICD might inhibit early branch-
ing, leading to an unfolded endoderm from which a proper
regionalization of distal foregut structures cannot form. Our
data clearly show that the branching pattern within the
PDX1 domain of the early distal foregut is markedly
altered, as neither the dorsal nor the ventral bud is clearly
defined. It is possible that this unfolded pancreas–endoderm
expands into the duodenum and stomach. Thus, it is possi-
ble that the elevated expression of Notch1ICD throughout the
PDX1 domain leads to repatterning of the endoderm. We
cannot, however, determine whether this is due to altered
specification of the foregut and midgut endoderm or is
caused by deregulated growth of the epithelium.
Notch1 signaling inhibits endocrine pancreatic
differentiation
Previous studies have shown that absence of Hes1, Dll1,
or RBP-j causes increased pancreatic endocrine differen-
tiation, leading to the loss of the pancreatic progenitor cells.
We initially hypothesized that expression of Notch1ICD in
the pancreatic precursor cells would lead to the opposite
effect and reduce endocrine cell differentiation. Although
the pancreatic domain is irregular and the initial budding
morphology is disrupted, we observe a decrease in the
density of glucagon-expressing endocrine cells within the
PDX1/Nkx6.1-expressing domain at e10.5 and e12.5. These
results support the idea that Notch1 suppress endocrine
differentiation. However, endocrine differentiation is not
completely blocked. Reduced numbers of Ngn3 cells are
observed, but a small number of cells have clearly differ-
entiated. These cells apparently follow the differentiation
program similar to endocrine cells in the wild-type embryos
and activate the homeodomain factors Isl1 and Pax6. Why
is Notch1ICD not blocking the development of these cells?
Several possibilities exist that may provide an explanation.
First, we do not know the amount of Notch1ICD produced by
the PDX1 promoter, nor do we know whether the resulting
protein is indeed constitutively active at all times in the
precursor cells. Signaling mechanisms that attenuate, or
remove, intracellular Notch1 in vivo are known (Fryer et al.,
2002; Lamar et al., 2001; Oberg et al., 2001; Qiu et al.,
2000; Santolini et al., 2000; Shen et al., 2002). This could
also explain why we observe Notch1ICD in the cytoplasm at
18.5. Alternatively, signals not controlled by Notch1 might
downregulate pdx1, thus making it possible for glucagon
cells to form with some delay. Finally, scattered wild-type
cells, as a result of local chimerism or mosaic expression of
the transgene (Gannon et al., 2000), may explain the pres-
ence of endocrine cells. Another explanation is that endo-
crine cells form due to the presence of sufficient levels of
Ngn3 expression to overcome the threshold imposed by the
Notch1ICD. Initial ngn3 promoter activation is likely con-
ferred by unknown local morphogenetic signals. These are
presumably still present in the transgenic pancreas, explain-
ing why Ngn3 is detectable at a reduced level. Finally, we
also have to take into consideration that the pdx1 promoter
itself may be influenced by the early changes in fore/midgut
structures. We do observe a gradual decline in PDX1 im-
munoreactivity at later stages (e18.5), which should lead to
a decline in transgene expression as well. This may trigger
further endocrine differentiation events, which otherwise
could have been antagonized by high levels of Notch1ICD.
Late endocrine cell development
Despite the problematic issues in evaluating endocrine
cell development at later stages, some of our data suggest
that Notch signaling may play a role in binary fate alloca-
tion in the endocrine lineage tree of the pancreas. Most
importantly, we find a skewed ratio of /-cells, where the
numbers of mature insulin cells are reduced to a greater
extent than the numbers of glucagon cells. However, other
markers of the -cell show that a population of insulin-
negative, but Nkx6.1-, PDX1- and IAPP-expressing cells
are present, indicating that the -cell differentiation pro-
Fig. 6. Impaired pancreatic exocrine differentiation of pPDX1-Notch1ICD embryos. (A–D) Amylase and carboxypeptidase A are highly expressed in the
normal exocrine pancreas (e18.5, A, C), but neither is detectable in the reduced pancreatic epithelium of the transgenic embryo (B, D). (E, F) The bHLH
factor Mist1 is expressed in exocrine nuclei of WT (arrowhead, E) embryos (e18.5), but absent in the transgenic embryo (F). The antibody gives rise to some
background staining in the endocrine cells (open arrowhead). (G, H) Amylase immunofluorescent staining of e14.5 wild type (G) and transgenic pancreas
(H). Asterisks mark autofluorescent blood cells (G, H). Normally, exocrine terminal differentiation commences at e13.5, observed here as a scattered
distribution of amylase-positive cells in primarily exterior domains of the organ (G). In the transgenic pancreas, a complete absence of exocrine differentiation
is observed (H). Scale bars are 25 m.
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gram has not been completed. One possibility is that
the high-level pdx1 promoter activity has led to transgene
expression in these cells, subsequently altering their pheno-
type. We have previously found that Hes1 strongly re-
presses the insulin promoter (J.J., unpublished observa-
tions), so this scenario appears likely. Also, we find the
presence of a significant number of -cells, many of which
express Nkx6.1. We speculate that expression of Notch1 in
the developing -cells may have led to a fate change along
the -cell pathway, resulting in a mixed /-cell phenotype.
Still, investigations exerting more elaborate control of
Notch1 activation in the endocrine cell types at later stages
are required to demonstrate that Notch signaling is involved
in controlling a binary /-cell fate decision. Alternatively,
the high numbers of somatostatin Nkx6.1 cells might be
due to an arrest of -cell differentiation at an Nkx6.1 stage.
Notch signaling and the exocrine pancreatic fate choice
Previous studies have suggested that exocrine pancreatic
development is promoted by Notch1 (Apelqvist et al., 1999;
Jensen et al., 2000b). However, we find that exocrine dif-
Fig. 8. Duct formation in the pPDX1-Notch1ICD embryos (e18.5). (A) In
wild type embryos, the ducts (arrows) and beta-cells (circle) are GLUT2-
positive. Glucagon cells are labeled in red in the periphery of the forming
islets. (C) Wild-type stomach is GLUT2-negative, while in the transgenic
embryos, the rudimentary pancreas (B) and the epithelium of the cyst (D)
are GLUT2-positive. In the cyst, the staining is patchy as indicated with the
arrowheads. (E) Wild type pancreas stained for PDX1 and insulin. Strong
PDX1 cells are found in the forming islets, and weakly expressing cells are
found in the duct tissue. (F) Transgenic tissue stained for PDX1 and
insulin. Strong PDX1 immunoreactivity is found in the cells budding off
from the cyst (nonfilled arrows), and weaker expressing cells are found in
the cyst (arrowheads), like in normal duct cells. Scale bar, 50 m.
Fig. 7. Endocrine cell phenotype analysis in the rudimentary pancreas
(e18.5). Only few weakly expressing insulin-positive cells are formed;
like in wild type (A), they do not coexpress glucagon (B). Like normal
beta cells (C), they express Nkx6.1 (D). Multiple Nkx6.1-expressing
cells not expressing insulin are observed in the transgenic pancreas,
whereas in normal pancreas, these are largely overlapping. A large
population of PDX1-positive, but insulin-negative cells is also present
in the rudimentary pancreas (F). The few insulin-positive cells express
PDX1 as in nontransgenic pancreas (E). Insulin cells express GLUT2 in
the wild-type pancreas (G) but not in the transgenic embryo (H). In
wild-type embryos, only 8% (19 cells out of 244 cells) of the IAPP-
expressing cells do not express insulin (I), whereas in pPDX1-
Notch1ICD embryos, approximately 50% (29 cells out of 63 cells) of
IAPP-positive cells do not express insulin (J). In pPDX1-Notch1ICD
embryos, approximately 70% of the somatostatin cells express Nkx6.1
(L), whereas in wild type, approximately 10% expresses Nkx6.1 (K).
Scale bar, 25 m.
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ferentiation is completely blocked by Notch1ICD expression.
The suggestion that exocrine development is promoted by
Notch was primarily based on two different observations.
First, Notch1 is expressed in the exocrine cells after they
complete differentiation (Jensen et al., 2000b; Lammert et
al., 2000). The fact that Notch1 is expressed both prior to,
and after differentiation, led us to suggest that it may have
played a role in selection of that lineage. The second reason
favoring a Notch-mediated exocrine fate allocation is based
on the observation that overexpression of Notch3ICD under
the pdx1 promoter leads to inhibition of the exocrine fate
(Apelqvist et al., 1999). This conclusion was based on the
observation that Notch3ICD is capable of antagonizing
Notch1ICD in a transfection assay (Beatus et al., 1999).
However, the intracellular domains of Notch1 and Notch3
are quite similar so it is possible that Notch3ICD and
Notch1ICD may repress exocrine development using the
same mechanism and that it is the sustained Notch (-1 or -3)
activity that blocks exocrine differentiation.
Possibility of Hes1-dependent and -independent effects of
Notch1 in the endoderm
An intriguing observation from our data is that Hes1 is
not uniformly expressed within the transgenic domain, and
this argues for Hes1 expression being strongly influenced by
other signaling mechanisms. We find Hes1 expressed within
the PDX1 domain with a scattered distribution, not unlike
that of wild type epithelium. As Hes1 is the best character-
ized target gene for Notch1, it is a surprise that this is not
activated to a higher extent within the transgenic-expressing
domain. This could be due to the nature of the oscillatory
expression pattern recently described for Hes1, making it
impossible to achieve uniform expression of the Hes1
(Hirata et al., 2002). Alternatively, Notch1 might work
through other target genes in the pancreas. Notch1 has been
shown to activate Hes5, Hes7, HRT1, HRT2, HRT3 (also
known as Hey, Hesr, Herp, CHF, Gridlock). Of these,
HRT1 and HRT3 are expressed at significant levels in the
pancreas (J.H., unpublished data) (Iso et al., 2003). Finally,
a second pathway may be used by Notch1ICD to block
differentiation, and Su(h)/Hes1-independent effects of
Notch signaling have previously been described. For in-
stance, Notch1ICD will block myogenesis, without induction
of endogenous Hes1 (Shawber et al., 1996).
We have here observed that increased Notch-signaling
leads to an almost complete block of pancreatic cell differ-
entiation. Based on our previous data, we expected this to
include the repression of endocrine cell differentiation, but
our finding that Notch1 similarly operates to inhibit exo-
crine cell differentiation was unexpected. Our data suggest
that Notch signaling could act to maintain the pancreatic
precursor state. A better knowledge of the pancreatic pre-
cursor cell state is important if such cells are to be used for
a future cell replacement of insulin-producing cells in the
type I diabetic patient through an expansion/conversion
strategy of either ES-cells or dedicated pancreatic stem
cells. We believe our data presented here may prove helpful
in showing at least part of the role that Notch1 plays in
pancreatic development.
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